Vestal Point Capital, LP Applied Therapeutics Inc. Transaction History
Vestal Point Capital, LP
- $1.9 Trillion
- Q2 2025
A detailed history of Vestal Point Capital, LP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 11,500,000 shares of APLT stock, worth $5.06 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
11,500,000
Previous 11,500,000
-0.0%
Holding current value
$5.06 Million
Previous $5.62 Billion
36.37%
% of portfolio
0.19%
Previous 0.4%
Shares
5 transactions
Others Institutions Holding APLT
# of Institutions
80Shares Held
89.6MCall Options Held
152KPut Options Held
186K-
T. Rowe Price Investment Management, Inc. Baltimore, MD18.7MShares$8.22 Million0.0% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$4.97 Million4.26% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$3.43 Million1.64% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$2.89 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$2.08 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $21.1M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...